PriceTargets.com logo

Avantor - AVTR Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $27.69
  • Forecasted Upside: 30.56%
  • Number of Analysts: 13
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 11 Buy Ratings
  • 0 Strong Buy Ratings
$21.21 As of 12/20/2024 06:15 PM ET
▲ +0.19 (0.90%)

This chart shows the closing price for AVTR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Avantor Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AVTR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AVTR

Analyst Price Target is $27.69
▲ +30.56% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for Avantor in the last 3 months. The average price target is $27.69, with a high forecast of $34.00 and a low forecast of $23.00. The average price target represents a 30.56% upside from the last price of $21.21.

This chart shows the closing price for AVTR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 13 polled investment analysts is to moderate buy stock in Avantor. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
6/30/2023
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
9/28/2023
  • 0 strong buy ratings
  • 10 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
12/27/2023
  • 0 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
6/24/2024
  • 0 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
9/22/2024
  • 0 strong buy ratings
  • 12 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
11/21/2024
  • 0 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/21/2024

Latest Recommendations

  • 0 strong buy ratings
  • 11 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/28/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$30.00 ➝ $28.00
10/28/2024Robert W. BairdLower TargetOutperform ➝ Outperform$27.00 ➝ $26.00
10/25/2024BarclaysLower TargetOverweight ➝ Overweight$28.00 ➝ $25.00
10/8/2024UBS GroupLower TargetBuy ➝ Buy$30.00 ➝ $29.00
9/26/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$34.00 ➝ $34.00
8/27/2024Wells Fargo & CompanyInitiated CoverageOverweight$30.00
7/29/2024Morgan StanleyBoost TargetOverweight ➝ Overweight$28.00 ➝ $29.00
7/29/2024TD CowenBoost TargetBuy ➝ Buy$28.00 ➝ $31.00
7/29/2024BarclaysBoost TargetOverweight ➝ Overweight$25.00 ➝ $28.00
7/29/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$31.00 ➝ $31.00
7/29/2024Stifel NicolausBoost TargetBuy ➝ Buy$27.00 ➝ $28.00
7/29/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$26.00 ➝ $27.00
7/15/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$30.00 ➝ $31.00
7/10/2024CitigroupDowngradeBuy ➝ Neutral$30.00 ➝ $23.00
7/2/2024Evercore ISILower TargetOutperform ➝ Outperform$28.00 ➝ $27.00
6/28/2024BarclaysLower TargetOverweight ➝ Overweight$28.00 ➝ $25.00
4/29/2024Robert W. BairdLower TargetOutperform ➝ Outperform$27.00 ➝ $26.00
4/18/2024Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$23.00 ➝ $25.00
4/10/2024BarclaysBoost TargetOverweight ➝ Overweight$27.00 ➝ $30.00
4/4/2024Evercore ISIBoost TargetOutperform ➝ Outperform$26.00 ➝ $28.00
2/15/2024UBS GroupBoost TargetBuy ➝ Buy$25.00 ➝ $29.00
2/15/2024CitigroupBoost TargetBuy ➝ Buy$24.00 ➝ $30.00
2/15/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$26.00 ➝ $29.00
2/15/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$25.00 ➝ $26.00
2/15/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$28.00 ➝ $29.00
2/15/2024BarclaysBoost TargetOverweight ➝ Overweight$24.00 ➝ $27.00
1/26/2024Raymond JamesBoost TargetOutperform ➝ Outperform$22.50 ➝ $26.00
1/9/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$28.00
1/4/2024Evercore ISIUpgradeIn-Line ➝ Outperform$19.50 ➝ $26.00
12/13/2023Wolfe ResearchInitiated CoveragePeer Perform
12/12/2023Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$20.00 ➝ $22.00
12/11/2023BarclaysBoost TargetOverweight ➝ Overweight$21.00 ➝ $24.00
12/11/2023TD CowenUpgradeMarket Perform ➝ Outperform$21.00 ➝ $28.00
12/7/2023The Goldman Sachs GroupBoost TargetBuy ➝ Buy$23.00 ➝ $26.00
10/30/2023Morgan StanleyLower TargetOverweight ➝ Overweight$24.00 ➝ $22.00
10/30/2023BarclaysLower TargetOverweight ➝ Overweight$25.00 ➝ $21.00
10/30/2023Raymond JamesLower TargetOutperform ➝ Outperform$25.00 ➝ $22.50
9/29/2023BarclaysBoost TargetOverweight ➝ Overweight$23.00 ➝ $25.00
9/28/2023Sanford C. BernsteinInitiated CoverageMarket Perform$22.00
7/31/2023Royal Bank of CanadaBoost TargetOutperform$27.00 ➝ $28.00
7/31/2023Morgan StanleyLower TargetOverweight ➝ Overweight$26.00 ➝ $24.00
7/31/2023Raymond JamesLower TargetOutperform$28.00 ➝ $25.00
7/31/2023Evercore ISIDowngradeOutperform ➝ Inline$22.00 ➝ $21.00
7/31/2023Robert W. BairdLower TargetOutperform ➝ Outperform$24.00 ➝ $22.00
7/31/2023William BlairDowngradeOutperform ➝ Market Perform
7/31/2023BarclaysBoost TargetOverweight$22.00 ➝ $23.00
7/30/2023Bank of AmericaLower TargetBuy$27.00 ➝ $24.00
6/21/2023Royal Bank of CanadaInitiated CoverageOutperform$27.00
5/1/2023888Reiterated RatingMaintains
5/1/2023Robert W. BairdLower Target$27.00 ➝ $24.00
5/1/2023BarclaysLower Target$25.00 ➝ $22.00
4/30/2023Bank of AmericaLower Target$30.00 ➝ $27.00
4/4/2023BarclaysLower TargetOverweight$28.00 ➝ $25.00
2/8/2023Wells Fargo & CompanyBoost TargetOverweight$25.00 ➝ $28.00
2/6/2023Raymond JamesBoost TargetOutperform$26.00 ➝ $30.00
2/6/2023Robert W. BairdLower Target$29.00 ➝ $27.00
2/6/2023CitigroupBoost TargetBuy$25.00 ➝ $30.00
1/24/2023BarclaysBoost TargetOverweight$23.00 ➝ $26.00
1/10/2023Wells Fargo & CompanyLower TargetOverweight$27.00 ➝ $25.00
12/13/2022Deutsche Bank AktiengesellschaftInitiated CoverageHold$24.00
11/4/2022UBS GroupLower Target$33.00
11/1/2022CowenLower Target$26.00
10/31/2022Raymond JamesLower TargetOutperform$27.00 ➝ $26.00
10/31/2022Morgan StanleyLower TargetOverweight$30.00 ➝ $28.00
10/31/2022CitigroupLower Target$28.00 ➝ $25.00
10/31/2022Robert W. BairdLower TargetOutperform$32.00 ➝ $29.00
10/31/2022Wells Fargo & CompanyLower TargetOverweight$33.00 ➝ $27.00
10/31/2022Credit Suisse GroupLower TargetNeutral$32.00 ➝ $25.00
10/31/2022BarclaysLower TargetOverweight$25.00 ➝ $23.00
10/25/2022Morgan StanleyLower TargetOverweight$37.00 ➝ $30.00
10/18/2022Raymond JamesLower TargetOutperform$36.00 ➝ $27.00
10/13/2022The Goldman Sachs GroupLower TargetBuy$37.00 ➝ $32.00
10/6/2022Robert W. BairdLower TargetOutperform$35.00 ➝ $32.00
10/6/2022BarclaysLower TargetOverweight$30.00 ➝ $25.00
10/5/2022CitigroupUpgradeNeutral ➝ Buy$28.00
9/19/2022Stifel NicolausLower Target$35.00 ➝ $28.00
9/15/2022UBS GroupLower Target$42.00
9/15/2022KeyCorpLower TargetOverweight$51.00 ➝ $40.00
9/14/2022CowenDowngradeOutperform ➝ Market Perform$39.00 ➝ $28.00
9/14/2022CitigroupLower TargetNeutral$32.00 ➝ $28.00
9/14/2022CowenDowngradeOutperform ➝ Market Perform$39.00 ➝ $28.00
9/12/2022BarclaysLower TargetOverweight$33.00 ➝ $30.00
8/24/2022Credit Suisse GroupInitiated CoverageNeutral$32.00
8/9/2022BarclaysLower Target$33.00
8/9/2022Evercore ISILower Target$35.00
8/9/2022CowenLower Target$39.00
8/1/2022BarclaysLower TargetOverweight$37.00 ➝ $33.00
8/1/2022Raymond JamesLower TargetOutperform$40.00 ➝ $36.00
8/1/2022Robert W. BairdLower TargetOutperform$44.00 ➝ $34.00
8/1/2022CitigroupLower TargetNeutral$38.00 ➝ $32.00
8/1/2022Morgan StanleyLower TargetOverweight$40.00 ➝ $37.00
7/14/2022The Goldman Sachs GroupLower TargetBuy$42.00 ➝ $37.00
7/13/2022BarclaysLower TargetOverweight$40.00 ➝ $37.00
4/29/2022William BlairReiterated RatingOutperform
4/25/2022Wells Fargo & CompanyLower TargetOverweight$42.00 ➝ $33.00
4/19/2022CowenLower Target$50.00 ➝ $44.00
4/19/2022CowenLower Target$50.00 ➝ $44.00
4/18/2022Raymond JamesLower TargetOutperform$43.00 ➝ $40.00
4/4/2022Evercore ISILower TargetOutperform ➝ Outperform$44.00 ➝ $42.00
4/4/2022CitigroupDowngradeBuy ➝ Neutral$48.00 ➝ $38.00
2/7/2022Morgan StanleyLower TargetOverweight$46.00 ➝ $43.00
2/7/2022Raymond JamesLower TargetOutperform$47.00 ➝ $43.00
2/7/2022Robert W. BairdLower Target$44.00 ➝ $43.00
2/7/2022BarclaysBoost TargetOverweight$41.00 ➝ $44.00
1/27/2022BarclaysLower TargetOverweight$48.00 ➝ $41.00
12/9/2021CowenBoost TargetOutperform ➝ Outperform$48.00 ➝ $50.00
11/22/2021JPMorgan Chase & Co.Initiated CoverageOverweight
11/1/2021Raymond JamesBoost TargetOutperform$45.00 ➝ $47.00
11/1/2021The Goldman Sachs GroupReiterated RatingBuy$46.00
11/1/2021CitigroupBoost TargetBuy$45.00 ➝ $48.00
11/1/2021Robert W. BairdBoost TargetOutperform$41.00 ➝ $44.00
11/1/2021BarclaysBoost TargetOverweight$43.00 ➝ $48.00
10/14/2021CowenLower TargetOutperform$62.00 ➝ $47.00
9/10/2021Stifel NicolausBoost TargetBuy$43.00 ➝ $46.00
9/10/2021Credit Suisse GroupBoost TargetOutperform$47.00 ➝ $50.00
9/9/2021KeyCorpBoost TargetOverweight$45.00 ➝ $51.00
8/30/2021Raymond JamesInitiated CoverageOutperform$45.00
8/2/2021Truist FinancialBoost TargetBuy$35.00 ➝ $45.00
8/2/2021Morgan StanleyBoost TargetOverweight$38.00 ➝ $44.00
8/2/2021CitigroupBoost TargetBuy$40.00 ➝ $45.00
8/2/2021BarclaysBoost TargetOverweight$40.00 ➝ $43.00
8/2/2021Piper SandlerUpgradeNeutral ➝ Overweight$40.00 ➝ $45.00
7/30/2021Credit Suisse GroupBoost TargetOutperform$39.00 ➝ $42.00
7/30/2021Wells Fargo & CompanyBoost TargetOverweight$36.00 ➝ $44.00
7/30/2021KeyCorpBoost TargetOverweight$40.00 ➝ $45.00
6/4/2021The Goldman Sachs GroupInitiated CoverageBuy$40.00
4/29/2021Credit Suisse GroupBoost TargetOutperform$37.00 ➝ $39.00
4/29/2021Raymond JamesBoost TargetOutperform$34.00 ➝ $37.00
4/29/2021Morgan StanleyBoost TargetOverweight$35.00 ➝ $38.00
4/29/2021JPMorgan Chase & Co.Boost TargetOverweight$35.00 ➝ $40.00
4/29/2021Robert W. BairdBoost TargetOutperform$32.00 ➝ $36.00
4/29/2021Piper SandlerBoost TargetNeutral$28.00 ➝ $32.00
4/29/2021Stifel NicolausUpgradeHold ➝ Buy$40.00
3/8/2021BarclaysInitiated CoverageOverweight$33.00
3/2/2021BarclaysInitiated CoverageOverweight$33.00
2/4/2021CitigroupBoost Target$33.00 ➝ $35.00
2/4/2021Credit Suisse GroupBoost TargetOutperform$33.00 ➝ $34.00
2/4/2021Morgan StanleyBoost TargetOverweight$27.00 ➝ $35.00
2/4/2021Piper SandlerBoost TargetNeutral$21.00 ➝ $28.00
1/19/2021KeyCorpBoost TargetOverweight$33.00 ➝ $40.00
1/12/2021Raymond JamesBoost TargetOutperform$30.00 ➝ $34.00
12/16/2020Smith Barney CitigroupBoost Target$28.00 ➝ $33.00
11/9/2020KeyCorpUpgradeSector Weight ➝ Overweight$33.00
10/30/2020Smith Barney CitigroupBoost Target$24.00 ➝ $28.00
10/29/2020JPMorgan Chase & Co.Boost TargetOverweight$25.00 ➝ $28.00
10/29/2020Morgan StanleyBoost TargetOverweight$24.00 ➝ $27.00
10/29/2020Robert W. BairdBoost TargetOutperform$23.00 ➝ $27.00
10/28/2020Wells Fargo & CompanyBoost TargetOverweight$23.00 ➝ $28.00
10/12/2020Raymond JamesBoost TargetOutperform$23.00 ➝ $27.00
10/9/2020Jefferies Financial GroupBoost TargetBuy$25.00 ➝ $30.00
9/14/2020Morgan StanleyInitiated CoverageOverweight$24.00
8/3/2020Truist FinancialBoost TargetBuy$21.00 ➝ $29.00
7/30/2020Stifel NicolausBoost TargetHold$18.00 ➝ $21.50
7/30/2020Raymond JamesBoost TargetOutperform$17.00 ➝ $23.00
7/30/2020JPMorgan Chase & Co.Boost TargetOverweight$18.00 ➝ $25.00
7/30/2020Piper SandlerBoost TargetNeutral$16.00 ➝ $21.00
7/28/2020Credit Suisse GroupBoost TargetOutperform$18.00 ➝ $21.00
4/30/2020CSFBLower TargetOutperform$20.00 ➝ $18.00
4/30/2020Credit Suisse GroupLower TargetOutperform$20.00 ➝ $18.00
4/30/2020CitigroupBoost TargetBuy$16.00 ➝ $19.00
4/30/2020Stifel NicolausBoost TargetHold$15.00 ➝ $18.00
4/30/2020Raymond JamesLower TargetOutperform$19.00 ➝ $17.00
4/28/2020UBS GroupLower TargetBuy$22.00 ➝ $20.00
4/2/2020Stifel NicolausLower TargetHold$16.00 ➝ $15.00
3/26/2020BarclaysLower TargetOverweight$21.00 ➝ $19.00
3/20/2020CitigroupLower TargetBuy$22.00 ➝ $11.00
2/10/2020Raymond JamesLower TargetOutperform$20.00 ➝ $19.00
2/7/2020CowenReiterated RatingBuy$23.00
1/7/2020Wells Fargo & CompanyInitiated CoverageOverweight$22.00
1/7/2020CitigroupInitiated CoverageBuy$21.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

1.44 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 25 very positive mentions
  • 15 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
5/25/2024
  • 17 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 22 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 20 very positive mentions
  • 36 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 28 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 23 very positive mentions
  • 17 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 35 very positive mentions
  • 30 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024
  • 39 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2024

Current Sentiment

  • 39 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Avantor logo
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Read More

Today's Range

Now: $21.21
Low: $20.95
High: $21.47

50 Day Range

MA: $22.15
Low: $19.72
High: $25.06

52 Week Range

Now: $21.21
Low: $19.59
High: $28.00

Volume

10,967,709 shs

Average Volume

6,461,251 shs

Market Capitalization

$14.44 billion

P/E Ratio

46.11

Dividend Yield

N/A

Beta

1.29

Frequently Asked Questions

What sell-side analysts currently cover shares of Avantor?

The following sell-side analysts have issued stock ratings on Avantor in the last twelve months: Barclays PLC, Citigroup Inc., Deutsche Bank Aktiengesellschaft, Evercore ISI, JPMorgan Chase & Co., Morgan Stanley, Raymond James, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, TD Cowen, UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for AVTR.

What is the current price target for Avantor?

0 Wall Street analysts have set twelve-month price targets for Avantor in the last year. Their average twelve-month price target is $27.69, suggesting a possible upside of 30.6%. Royal Bank of Canada has the highest price target set, predicting AVTR will reach $34.00 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $23.00 for Avantor in the next year.
View the latest price targets for AVTR.

What is the current consensus analyst rating for Avantor?

Avantor currently has 2 hold ratings and 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for AVTR.

What other companies compete with Avantor?

Other companies that are similar to Avantor include Keysight Technologies, Fortive, Veralto, Teradyne and Revvity. Learn More about companies similar to Avantor.

How do I contact Avantor's investor relations team?

Avantor's physical mailing address is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. The company's listed phone number is (610) 386-1700 and its investor relations email address is [email protected]. The official website for Avantor is www.avantorsciences.com. Learn More about contacing Avantor investor relations.